第一作者:
Andrés J M,Ferreri
第一单位:
From the Unit of Lymphoid Malignancies (A.J.M.F.), UTMO & Hematology Unit, Department of Onco-Hematology (F.C.), and Medical Oncology Unit, Department of Oncology (M.R.), San Raffaele Scientific Institute, Milan; Department of Medical Oncology (A.A.B.), Bellaria-Maggiore Hospital, Azienda Unità Sanitaria Locale, Bologna; Division of Hematology (M.M.), Ospedale di Ancona; Department of Medical Oncology and Hematology (M.B.), Istituto Clinico Humanitas, Rozzano; Division of Medical Oncology A (M.S.), National Cancer Institute, Aviano; Division of Hematology (F.I.), Ospedale di Reggio Emilia; Division of Hematology (F.Z.), Ospedale di Udine; Division of Hematology (C.S.), Ospedale di Reggio Calabria; Division of Hematology (F.B.), Ospedale Maggiore di Novara; Division of Hematology (G.C.), Istituto Nazionale dei Tumori Pascale di Napoli; and the Division of Hematology (L.B.), Ospedale Maggiore di Milano, Italy.
作者:
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);中枢神经系统肿瘤(Central Nervous System Neoplasms);综合疗法(Combined Modality Therapy);阿糖胞苷(Cytarabine);无病生存(Disease-Free Survival);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);伊达比星(Idarubicin);淋巴瘤(Lymphoma);男(雄)性(Male);甲氨蝶呤(Methotrexate);缓解诱导(Remission Induction);噻替派(Thiotepa);治疗结果(Treatment Outcome)
DOI
10.1212/WNL.0000000000000314
PMID
24634458
发布时间
2014-04-15
- 浏览27

Neurology
1370-3页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文